Hypertension Trial, Recruiting NCT07049783 Sponsor: Freda Patterson Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07049783
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 39 years old
  • People whose resting blood pressure falls within a specific range — at or above 120/80 mmHg but below 140/90 mmHg (sometimes called "elevated" or "stage 1" blood pressure — confirm with trial site if unsure where your reading falls)

Who may not be able to join:

  • People who have been diagnosed with, or have a history of, a long-term or immune-related illness such as heart disease, diabetes or other metabolic conditions, kidney disease, hormonal disorders, or cancer
  • People who have been diagnosed with, or have a history of, a sleep disorder such as sleep apnea, insomnia, or restless leg syndrome
  • People with alcohol or drug dependence
  • People assessed as being at elevated risk for a sleep disorder (confirm with trial site on how this is assessed)
  • People assessed as being at elevated risk for clinical depression (confirm with trial site on how this is assessed)
  • People whose blood pressure is considered normal (below 120/80 mmHg) or is at stage 2 high blood pressure or higher (at or above 140/90 mmHg)
  • People whose body mass index (BMI) is below 18.5 or above 35 kg/m²
  • People who currently use sleep aids or supplements such as melatonin
  • People who currently use medications that affect blood vessels or blood pressure, such as blood pressure medications or weight loss medications
  • People who do 300 minutes or more of moderate-to-vigorous physical activity per week
  • People who are currently pregnant or breastfeeding
  • People who have smoked at least one cigarette in the past month
  • People who have worked night shifts or rotating shifts within the last 3 months
  • People for whom aerobic exercise would be medically inadvisable (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 302-831-6588

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Freda Patterson
Registry
ClinicalTrials.gov
Start date
22 July 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Average daytime systolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov